BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37955670)

  • 1. Radiomics for the identification of extraprostatic extension with prostate MRI: a systematic review and meta-analysis.
    Ponsiglione A; Gambardella M; Stanzione A; Green R; Cantoni V; Nappi C; Crocetto F; Cuocolo R; Cuocolo A; Imbriaco M
    Eur Radiol; 2024 Jun; 34(6):3981-3991. PubMed ID: 37955670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-based nomograms and radiomics in presurgical prediction of extraprostatic extension in prostate cancer: a systematic review.
    Calimano-Ramirez LF; Virarkar MK; Hernandez M; Ozdemir S; Kumar S; Gopireddy DR; Lall C; Balaji KC; Mete M; Gumus KZ
    Abdom Radiol (NY); 2023 Jul; 48(7):2379-2400. PubMed ID: 37142824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of prediction models for extraprostatic extension in prostate cancer: a systematic review and meta-analysis.
    Zhu M; Gao J; Han F; Yin L; Zhang L; Yang Y; Zhang J
    Insights Imaging; 2023 Aug; 14(1):140. PubMed ID: 37606802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based radiomics for prediction of extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
    Wen J; Liu W; Zhang Y; Shen X
    Radiol Med; 2024 May; 129(5):702-711. PubMed ID: 38520649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
    Tabnak P; HajiEsmailPoor Z; Baradaran B; Pashazadeh F; Aghebati Maleki L
    Acad Radiol; 2024 Mar; 31(3):763-787. PubMed ID: 37925343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
    Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
    Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diagnostic Performance of the Length of Tumor Capsular Contact on MRI for Detecting Prostate Cancer Extraprostatic Extension: A Systematic Review and Meta-Analysis.
    Kim TH; Woo S; Han S; Suh CH; Ghafoor S; Hricak H; Vargas HA
    Korean J Radiol; 2020 Jun; 21(6):684-694. PubMed ID: 32410407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning for the identification of clinically significant prostate cancer on MRI: a meta-analysis.
    Cuocolo R; Cipullo MB; Stanzione A; Romeo V; Green R; Cantoni V; Ponsiglione A; Ugga L; Imbriaco M
    Eur Radiol; 2020 Dec; 30(12):6877-6887. PubMed ID: 32607629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
    Jia LL; Zheng QY; Tian JH; He DL; Zhao JX; Zhao LP; Huang G
    Front Oncol; 2022; 12():1026216. PubMed ID: 36313696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the different versions of Partin tables in predicting extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
    Eissa A; Elsherbiny A; Zoeir A; Sandri M; Pirola G; Puliatti S; Del Prete C; Sighinolfi MC; Micali S; Rocco B; Bianchi G
    Minerva Urol Nefrol; 2019 Oct; 71(5):457-478. PubMed ID: 30957478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
    Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance radiomics for prediction of extraprostatic extension in non-favorable intermediate- and high-risk prostate cancer patients.
    Losnegård A; Reisæter LAR; Halvorsen OJ; Jurek J; Assmus J; Arnes JB; Honoré A; Monssen JA; Andersen E; Haldorsen IS; Lundervold A; Beisland C
    Acta Radiol; 2020 Nov; 61(11):1570-1579. PubMed ID: 32108505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction.
    Pan K; Yao F; Hong W; Xiao J; Bian S; Zhu D; Yuan Y; Zhang Y; Zhuang Y; Yang Y
    Br J Radiol; 2024 Feb; 97(1154):408-414. PubMed ID: 38308032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
    Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
    Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
    Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
    Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Based on Multiparametric Magnetic Resonance Imaging to Predict Extraprostatic Extension of Prostate Cancer.
    Xu L; Zhang G; Zhao L; Mao L; Li X; Yan W; Xiao Y; Lei J; Sun H; Jin Z
    Front Oncol; 2020; 10():940. PubMed ID: 32612953
    [No Abstract]   [Full Text] [Related]  

  • 19. MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study.
    Cuocolo R; Stanzione A; Faletti R; Gatti M; Calleris G; Fornari A; Gentile F; Motta A; Dell'Aversana S; Creta M; Longo N; Gontero P; Cirillo S; Fonio P; Imbriaco M
    Eur Radiol; 2021 Oct; 31(10):7575-7583. PubMed ID: 33792737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Extraprostatic Extension Grade: Accuracy and Clinical Incremental Value in the Assessment of Extraprostatic Cancer.
    Xiang JY; Huang XS; Xu JX; Huang RH; Zheng XZ; Xue LM; Liu YL
    Biomed Res Int; 2022; 2022():3203965. PubMed ID: 36082151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.